Dr. Thomas R. Insel, Director, NIMH, will
present on the prevalence and global burden of depression,
its enormous economic impact, and new advances in treatment
at the World Economic Forum annual meeting. Depression is
the leading cause of medical disability for people worldwide
age 15-44 according to the World Health Organization’s World
Health Report on the global burden of disease. Depression
is common among the world’s population, resulting in significant
economic costs. Dr. Insel will also participate in two additional
sessions — one that focuses on funding for mental health
research and innovation, and another that addresses urbanization
from a public health perspective.

Why:

The World Economic Forum Annual Meeting, “Shaping
the Global Agenda — The Shifting Power Equation.” The
World Economic Forum is an independent international organization
committed to improving the state of the world by engaging
leaders in partnerships to shape global, regional and industry
agendas (http://www.weforum.org/en/events/AnnualMeeting2007/index.htm).
The annual meeting is the Forum’s flagship event that engages
leaders from business, politics, religious groups and non-government
organizations to shape the global, regional and industry
agendas.

When:

January 24-28, 2007

Where:

Davos, Switzerland

More Info:

To arrange for an interview contact Mary Partlow,
NIMH Press Office, 301-443-4536. Dr. Insel will be available
for interview on-site or by phone.

The National Institute of Mental Health (NIMH) mission is to reduce
the burden of mental and behavioral disorders through research on mind,
brain, and behavior. More information is available at the NIMH website: http://www.nimh.nih.gov/.

The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and is
a component of the U.S. Department of Health and Human Services. It is
the primary federal agency for conducting and supporting basic, clinical
and translational medical research, and it investigates the causes, treatments,
and cures for both common and rare diseases. For more information about
NIH and its programs, visit www.nih.gov.